Skip to main content
. 2014 Aug 1;24(8):1275–1281. doi: 10.1089/thy.2014.0053

FIG. 2.

FIG. 2.

Survival analysis of FTC patients. (A) Overall survival in the FTC patients according to the RAS mutation status. There was no difference in the overall survival between RAS mutant FTC and wild-type FTC patients. (B) Overall survival in the FTC patients according to NRAS codon 61 mutation status demonstrated no difference between NRAS codon 61 mutant-FTC and NRAS codon 61 wild-type FTC patients.